谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Patient-reported Outcomes (pros) with Talazoparib (TALA) Plus Enzalutamide (ENZA) Vs. Placebo (PBO) Plus ENZA in Men with Metastatic Castration-Resistant Prostate Cancer (mcrpc): Subgroup Analysis of Patients with Novel Hormonal Therapy (NHT) Pretreatment in the TALAPRO-2 Study.

Ugo De Giorgi,Arun Azad,Karim Fizazi,Nobuaki Matsubara,Fred Saad,Jae Young Joung,Peter C. C. Fong,Robert J. Jones,Stefanie Zschaebitz,Jan Oldenburg,Neal D. Shore,Curtis Dunshee,Joan Carles,Andre P. Fay,Paul Cislo,Melissa Kirker,Cynthia G. Healy,Alexander Niyazov,Neeraj Agarwal

JOURNAL OF CLINICAL ONCOLOGY（2024）

引用 0|浏览3
暂无评分
关键词
261-492-6491,283-2494-5577-2829-12292,261-492-199-2823,60,1866,60
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要